Virginia officials recently celebrated the opening of Phlow’s new pharmaceutical facility in Petersburg, branding Petersburg as a pivotal hub for the industry. Dr. Kendra Brinkley, Dean of the STEM program at Reynolds Community College, highlighted the...
Richmond, VA., May 6, 2024 – Phlow Corp., a U.S.-based certified B Corporation leveraging advanced development and manufacturing processes to re-imagine the domestic production of pharmaceutical products critical to U.S. healthcare, announced today that it has...
Initial product to help save lives by improving essential multi-medication administration during sudden cardiac arrest. The Virginia Innovation Partnership Corporation (VIPC) today announced that Virginia Venture Partners (VVP), its equity investment...
Phlow Corp., a Public Benefit Corporation, today announced that it has joined a select group of purpose-driven businesses by becoming the first pharmaceutical manufacturer based in America to earn B Corporation™ (B Corp™) certification. The new certification further...
Phlow Corp., a Public Benefit pharmaceutical manufacturer, announced today the appointment of Kerry Ingalls and Guy Villax to its Board of Directors amid a period of rapid growth and operational scale-up of facilities for Phlow. Ingalls and Villax will join...
